Show Notes
In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive news from Baxter and Conformis, the hopeful projections from Edwards, and the cautionary tone from Medtronic.
We also interview Mark McIlduff, general manager, US, at the newly named CRO, Avania on the state of clinical trials. What changes might we expect in the future? Mark brings great insights.
Guests are:
• Mark McIlduff, general manager, US, Avania
Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.
